Company · CIK 0001473579 · SIC 2834 — Pharmaceutical Preparations
Boston Therapeutics, Inc. · BTHE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2015 PForm 4 → | Jun 8, 1:12 pm EDT | Dale H ConawayDirector | 5,000 | $0.12 | $600 | 7,100 | +238% | plan? late |
| May 14, 2015 PForm 4 → | May 18, 1:35 pm EDT | David PlattCEO and Chairman, Director, 10% Owner | 6,000 | $0.1246 | $748 | 7,561,985 | +0.08% | plan? |
| Mar 18, 2015 PForm 4 → | Mar 20, 4:26 pm EDT | Henry Jemil EsberDirector | 9,000 | $0.20 | $1,800 | 13,000 | +225% | plan? |
| Mar 10, 2015 PForm 4 → | Mar 16, 2:52 pm EDT | Alan M HobermanDirector | 5,000 | $0.22 | $1,100 | 5,000 | — | plan? late |
| Mar 10, 2015 PForm 4 → | Mar 11, 2:41 pm EDT | Anthony Don SquegliaChief Financial Officer | 10,000 | $0.22 | $2,200 | 128,350 | +8.45% | plan? |
| Mar 9, 2015 PForm 4 → | Mar 10, 4:02 pm EDT | David PlattCEO and Chairman, Director, 10% Owner | 10,000 | $0.2188 | $2,188 | 7,555,985 | +0.13% | plan? |
| Feb 17, 2015 PForm 4 → | Feb 19, 1:54 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 250 | $0.58 | $145 | 7,545,985 | +0.00% | plan? |
| Feb 12, 2015 PForm 4 → | Feb 13, 12:50 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 250 | $0.51 | $128 | 7,545,735 | +0.00% | plan? |
| Feb 2, 2015 PForm 4 → | Feb 4, 4:44 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 600 | $0.4327 | $260 | 7,545,485 | +0.01% | plan? |
| Jan 27, 2015 PForm 4 → | Jan 29, 3:43 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 800 | $0.4497 | $360 | 7,544,885 | +0.01% | plan? |
| Jan 23, 2015 PForm 4 → | Jan 27, 3:28 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 500 | $0.40 | $200 | 7,544,085 | +0.01% | plan? |
| Jan 20, 2015 PForm 4 → | Jan 23, 4:03 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 3,000 | $0.34 | $1,020 | 7,543,585 | +0.04% | plan? late |
| Jan 15, 2015 PForm 4/A → | Jan 20, 6:16 am EST | David PlattCEO and Chairman, Director, 10% Owner | 600 | $0.5999 | $360 | 7,540,585 | +0.01% | plan? |
| Jan 15, 2015 PForm 4 → | Jan 16, 5:01 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 1,000 | $0.5999 | $600 | 7,540,985 | +0.01% | plan? amended |
| Jan 9, 2015 PForm 4 → | Jan 12, 5:00 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 1,500 | $0.6262 | $939 | 7,539,985 | +0.02% | plan? |
| Jan 7, 2015 PForm 4 → | Jan 8, 5:33 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 700 | $0.6505 | $455 | 7,538,485 | +0.01% | plan? |
| Jan 5, 2015 PForm 4 → | Jan 7, 3:19 pm EST | David PlattCEO and Chairman, Director | 100 | $0.5999 | $60 | 7,537,785 | — | plan? |
| Dec 31, 2014 PForm 4 → | Jan 5, 2015, 12:04 pm EST | David PlattCEO and Chairman, Director, 10% Owner | 1,100 | $0.648 | $713 | 7,537,685 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2017 PForm 4 → | Feb 13, 2018, 4:30 pm EST | Carl W RauschChief Executive Officer, Director | 6,000,000 | $0.1333 | $800,000 | 2,000,000 | — | late |
| Sep 25, 2014 AForm 4 → | Mar 20, 2015, 4:26 pm EDT | Henry Jemil EsberDirector | 6,000 | — | — | 228,000 | — | late |